TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
CAI

Caris Life Sciences, Inc.

Healthcare · Biotechnology · —

30.90$ +9.6% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Caris Life Sciences, Inc. (CAI): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/04/2026.

Next report 11/04/2026
Last report 08/05/2026
Earnings surprise by quarter (%)
Q2 25 · -404.6 % 25 Q3 25 · 200.0 % 25 Q4 25 · 2,700.0 % 25 Q1 26 · 91.0 % 26 Q2 26 · -5,300.0 % 26

EPS estimate beaten

Full history 3 of 6 quarters (50%)

Earnings Call Transcripts

Search all transcripts →

  • 08/05/2026 Earnings Call Q2 2026 Open →
  • 05/07/2026 Earnings Call Q1 2026 Open →
  • 02/27/2026 Earnings Call Q4 2025 Open →
  • 11/05/2025 Earnings Call Q3 2025 Open →

News on This Stock

  • 09/14/2026 Caris Life Sciences, Inc. (CAI): Regulation FD Disclosure · sec.gov Open ↗
  • 08/05/2026 Caris Life Sciences, Inc. (CAI): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?